Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
727天前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
994天前
Yen Falls Amid Risk-on Mood
The Japanese yen weakened against other major currencies in the Asian session on Monday as Asian stock markets traded higher, amid expectations of the three-year-plus war between Russia and Ukraine ending soon, with U.S. President Donald Trump saying he and Russian President Putin discussed land transfers and security guarantees for Ukraine and had "largely agreed".
RTTNews
|
1小时47分钟前
Yen Falls Against Majors
The Japanese yen weakened against other major currencies in the Asian session on Monday.
RTTNews
|
1小时57分钟前
European Shares Seen Opening Up On Russia-Ukraine Hopes
European stocks are seen opening a tad higher on Monday as hope prevails for a swift resolution to the Russia-Ukraine conflict.
RTTNews
|
2小时6分钟前
Sensex, Nifty Rally As Automakers Surge On Modi's Big GST Reform Push
Indian shares opened on a buoyant note on Monday after S&P Global Ratings upgraded India's sovereign ratings and Prime Minister Narendra Modi promised next generational GST reforms by Diwali, which will bring down the tax burden on consumers as well as MSMEs.
RTTNews
|
3小时18分钟前
Australian Market Trims Early Losses In Mid-market
The Australian stock market is trimming its early losses in choppy mid-market trading on Monday, after opening in the red and briefly treading in to the green, reversing some of the gains in the previous two sessions, following the mixed cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is staying above the 8,900.00 level, with weakness in mining and energy stocks.
RTTNews
|
4小时11分钟前
Asian Markets Trade Mostly Higher
Asian stock markets are trading mostly higher on Monday, following the mixed cues from Wall Street on Friday, amid expectations of the three-year-plus war between Russia and Ukraine ending soon, with U.S. President Donald Trump saying he and Russian President Putin discussed land transfers and security guarantees for Ukraine, and had "largely agreed". Asian markets closed mostly higher on Friday.
RTTNews
|
4小时34分钟前
